http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
만성신부전 환자에서의 초기 투석 시작시와 장기 투석 후의 임상적, 실험적 특징의 고찰
김호중(Ho Jung Kim),박일규(Ile Kyu Park),한상웅(Sang Woong Han),양성규(Seong Kyu Yang),유준호 대한신장학회 2000 Kidney Research and Clinical Practice Vol.19 No.2
N/A Objective: We examined clinical and laoratory features retrospectively in 56 patients at the start and after the chronic maintenance hemodialysis in order to provide a more complete picture of the uremic symdrome in the dialysis era. for deciding the time when chronic hemodialysis must be started. Methods: The records of 56 patients began chro-nic hemodialysis treatment at the Han Yang University Hospital from 1995 august until 1997 august were reviewed retrospectively. The information gathered in-cluded demographic data, renal diagnosis, uremic symptoms, biochemical values. Results: The most prevalence of manifestation of uremia was general weakness(67.9%). Unexpected fin-dings were the wide ranges of serum creatinine levels(3.5 to 19.4mg/dL) and blood urea nitrogen levels (19 to 204mg/dL), creatinine clearance rate(1.2-17.4mL/ min), and the frequency of hyponatremia(19.6%), hypo-albuminemia(69.6%), and the anion gap above 14mByL was(66.7%). There was higher potassium leve1 in dia-betes mellitus patients than non-diabetes mellitus pa-tients(6.2±1.6mEq/L VS. 4.9±1.0mEq/L,p=01). Patients laboratory values were changed after the chronic main- tenance hemodialysis-Albumin(3.2±0.8 to 3.6±0.5gm/dL, p=0.01), calcium(7.6±1.2 to 8.7±1.9mg/dL, p=0.01), he-matocrit(23.0±4.7 to 27.7±4.2% , p=0.01), phosphorus (5.6±2.1 to 4,6±1.4mg/dL, p=0.01), pH(7.30±0,1 to 7.35±0.2, p>0.05), anion gap(22,0±11.0 to 12.1±8.8mg/dL, p>0.05). Conclusion: Finally, uremic symptoms were ex-pressed mainly gastro-intestinal and respiratory sym-ptoms. Chronic renal failure associated with diabetes mellitus was earlier on set of uremic symptoms and higher level of serum potassium level than other underlying diseases. Uremic symptoms and laboratory values were almost corrected but metabolic acidosis was not corrected significantly after the chronic main- tenance hemodialysis.
Myrinet 상에서 VMMC를 기반으로 하는 효율적인 MPI 구현 (pp.642-644)
김호중(Ho-joong Kim),손영철(Youn-Chul Sohn),장영배(Young-Bae Jang),이문상(Moon-Sang Lee),김명균(Myung-Kyun Kim),맹승렬(Seung Ryoul Maeng) 한국정보과학회 2000 한국정보과학회 학술발표논문집 Vol.27 No.1A
클러스터 시스템의 성능을 향상시키기 위해서는 Myrinet과 같은 고성능 통신망 인터페이스가 필수적이다. 그러나 Myrinet에서 동작하는 저수준 통신 계층들은 각기 고유한 기작을 사용하므로 호환성이 떨어진다. 따라서 MPI와 같은 통신 프로그래밍 표준을 효율적으로 구현하여 응용프로그램 수준에서 고성능과 호환성을 동시에 제공하여야 한다. 본 논문에서는 VMMC 통신 계층을 기반으로, 늦은 위치 갱신, 선택적 무복사 전송 등의 최적화 기법을 적용하여 우수한 성능의 MPI를 구현하였다.
김호중(Ho Joong Kim),최형석(Hyung Suk Choi),심태선(Tae Sun Shim),이혁표(Hyeok Pyo Lee),김영환(Young Whan Kim),허대석(Dae Seog Heo),한성구(Sung Koo Han),심영수(Young Soo Shim),김노경(Noe Kyeong Kim),김건열(Keun Youl Kim),한용철(Yong C 대한내과학회 1991 대한내과학회지 Vol.41 No.2
N/A Pulmonary toxicity is a potentially fatal complication of bleomycin, one of the well-known anti-cancer chemotherapeutics. The incidence of bleomyicn-induced pulmonary toxicity was reported as 2-40% and fatality, 1-2%. Bleomycin-induced pulmonary toxicity is sometimes progressive even after discontinuation of the drug, but there has been no specific treatment modalities other than prevention, Forced vital capacity (FVC) and carbon monoxide diffusing capacity (DLco) have been proposed as parameters valuable in predicting subclinical bleomycin-induced pulmonary toxicity, but there are still conflicting results. To discover the predicting factors for bleomycin-induced pulmonary toxicity, 15 patients treated with 6 cycles of cyclophophamide, vinblastine, prednisolone, bleomycin, adriamycin and procarbazine (COPBLAM- III) for non-Hodgkin's lymphoma at Seoul National University Hospital between March 1989 and March 1990 were studied prospectively. Routine physical examination, complete blood count, chest X-ray and pulmonary function test including DLco were done at initial diagnosis, then every 2 cycles and at restaging, and 1 month after the last treatment. The results were as follows: 1) Carbon monoxide diffusing dapacity (DLco) decreased from the 6th cycle (cumulative dose was average 347 u) and persisited thereafter, but the decrement was not dose-dependent. 2) There were no interval changes in forced vital capacity (FVC), forced expiratory volume 1-second (FEV1), FEU1/FVC, mean forced expiratory flow during middle half of the FVC (MEF), and MEF/FVC. 3) Based on radiological critieria, bleomycin-induced pulmonary toxicity developed in 1 patient (6.7%). At this point, the cumulative dosage of bleomycin was 312 u and DLco decreased by 57%. 4) If the predictive critieria was determined as 55% decrement of DLco, the false positive rate was 66.7%. In this study, no parameters were found to predict bleomycin-induced pulmonary toxicity. In conclusion, DLco is not a universally sensitive predictor of bleomycin-induced pulmonary toxicity, but may be a preceding parameter. It is recommended that for all patients who are administered over 300 u of bleomycin, a periodic physical examination, DLco and chest X-ray should be done for early detection of bleomycin-induced pulmonary toxicity. .